In vitro degradation of porous poly(l-lactic acid) foams
Source abstract
Abstract
This study investigated the in vitro degradation of porous poly(L-lactic acid) (PLLA) foams during a 46-week period in pH 7.4 phosphate-buffered saline at 37 degrees C. Four types of PLLA foams were fabricated using a solvent-casting, particulate-leaching technique. The three types had initial salt weight fraction of 70, 80, and 90%, and a salt particle size of 106-150 microm, while the fourth type had 90% initial weight fraction of salt in the size range 0-53 microm. The porosities of the resulting foams were 0.67, 0.79, 0.91, and 0.84, respectively. The corresponding median pore diameters were 33, 52, 91, and 34 microm. The macroscopic degradation of PLLA foams was independent of pore morphology with insignificant variation in foam weight, thickness, pore distribution, compressive creep behavior, and morphology during degradation. However, decrease in melting temperature and slight increase in crystallinity were observed at the end of degradation. The foam half-lives based on the weight average molecular weight were 11.6+/-0.7 (70%, 106-150 microm), 15.8+/-1.2 (80%, 106-150 microm), 21.5+/-1.5 (90%, 106-150 microm), and 43.0+/-2.7 (90%, 0-53 microm) weeks. The thicker pore walls of foams prepared with 70 or 80% salt weight fraction as compared to those with 90% salt weight fraction contributed to an autocatalytic effect resulting in faster foam degradation. Also, the increased pore surface/volume ratio of foams prepared with salt in the range 0-53 microm enhanced the release of degradation products thus diminishing the autocatalytic effect and resulting in slower foam degradation compared to those with salt in the range 106-150 microm. Formation and release of crystalline PLLA particulates occurred for foams fabricated with 90% salt weight fraction at early stages of degradation. These results suggest that the degradation rate of porous foams can be engineered by varying the pore wall thickness and pore surface/volume ratio.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: biodegradable polymer synthesis and properties · Botulinum Toxin and Related Neurological Disorders · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Patrick Jr CW, Mikos AG, McIntire LV, editors. Frontiers in tissue engineering. New York: Pergamon, 1998.10.1016/B978-008042689-1/50003-0 ↗
2. The importance of new processing techniques in tissue engineering10.1557/S088376940003181X ↗
3. Lu L, Mikos AG. Synthetic bioresorbable polymer scaffolds. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials science: an introduction to materials in medicine, 2nd ed. San Diego: Academic Press, in press.
4. Fabrication of controlled release biodegradable foams by phase separation10.1089/ten.1995.1.15 ↗
5. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers10.1002/jbm.820270104 ↗
6. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes10.1016/S0963-6897(97)00052-3 ↗
7. Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions10.1055/s-2008-1071153 ↗
8. Biocompatibility of a biodegradable matrix used as a skin substitute10.1002/jbm.820280504 ↗
9. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration10.1016/S0142-9612(98)00099-4 ↗
10. In vivo evaluation of poly(l-lactic acid) porous conduits for peripheral nerve regeneration10.1016/S0142-9612(99)00010-1 ↗
11. Evans GRD, Brandt K, Katz S, Chauvin P, Otto L, Bogle M, Wang B, Meszlenyi RK, Lu L, Mikos AG, Patrick Jr CW. Bioactive poly(l-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Exp Neurol, in press.10.1016/S0142-9612(01)00190-9 ↗
12. Host response to tissue engineered devices10.1016/S0169-409X(98)00023-4 ↗
13. Mechanisms of polymer degradation and erosion10.1016/0142-9612(96)85755-3 ↗
14. Degradation rates of oral resorbable implants (polylactates and polyglycolates)10.1002/jbm.820110507 ↗
15. Biodegradable polymers for use in surgery-poly(glycolic)/poly(lactic acid) homo and copolymers. 2
16. Poly(l-lactide)10.1016/0142-9612(93)90121-H ↗
17. Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids10.1163/156856294X00581 ↗
18. Degradation of polydispersed poly(l-lactic acid) to modulate lactic acid release10.1016/0142-9612(95)98816-W ↗
19. Water fugacity in absorbing polymers10.1002/(SICI)1097-4636(199724)38:4<337::AID-JBM5>3.0.CO;2-P ↗
20. Preparation and characterization of poly(l-lactic acid) foams10.1016/0032-3861(94)90953-9 ↗
21. Neter · 1990
22. Laminated three-dimensional biodegradable foams for use in tissue engineering10.1016/0142-9612(93)90049-8 ↗
23. Degradation of poly(lactic-co-glycolic acid) microspheres10.1016/0142-9612(95)93575-X ↗
24. The effects of porosity on in vitro degradation of polylactic acid–polyglycolic acid implants used in repair of articular cartilage10.1089/ten.1998.4.53 ↗
25. Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media Part 2: Degradation of lactide-glycolide copolymers
26. In vitro degradation of thin poly(dl-lactic-co-glycolic acid) films10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F ↗
27. Degradation of poly(dl-lactic acid) microspheres10.1016/0168-3659(94)90263-1 ↗
28. Characterization of PLGA microspheres for the controlled delivery of IL-α for tumor immunotherapy10.1016/S0168-3659(96)01496-4 ↗
29. Effects of biodegradable polymer particles on rat marrow derived stromal osteoblasts in vitro10.1016/S0142-9612(98)00022-2 ↗